UPDATE 1-Lilly stomach cancer drug prolongs life in colon cancer study
September 12, 2014 at 10:44 AM EDT
Sept 12 (Reuters) - Eli Lilly and Co's Cyramza stomach-cancer drug prolonged survival of patients with advanced colon cancer in a late-stage study, the U.S. drugmaker said on Friday.
